Maximising use of population data on cardiometabolic diseases

David Flood, David Guwatudde, Albertino Damasceno, Jennifer Manne-Goehler, Justine I. Davies, Lindsay Jaacks

Research output: Contribution to journalComment/debatepeer-review


The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling
up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems. As we have previously argued
in this journal, building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly
essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system
Original languageEnglish
Pages (from-to)154-157
JournalThe Lancet Diabetes and Endocrinology
Issue number3
Early online date10 Jan 2022
Publication statusPublished - Mar 2022


Dive into the research topics of 'Maximising use of population data on cardiometabolic diseases'. Together they form a unique fingerprint.

Cite this